The first baby was born via IVF more than 40 years ago.
Since then, the technology has helped millions of women get pregnant.
However, IVF can put significant emotional, psychological, and financial strain on patients.
It is often unsuccessful on the first attempt.
Some try multiple times without success.
For many, IVF ultimately does not lead to parenthood.
40% off TNW Conference!
Based on 20 years of fertility research, thestartuphas developed threetherapeutic treatments that reduce genetic errors in eggs.
Schuh is a world-leading fertility expert at the Max Planck Institute in Munich.
Ovo Labs has already proven that it can improve the quality of eggs in old mice.
The company has also shown it can successfully treat isolated human eggs.
However, its technology is not yet approved for human trials.
If the treatment gets the green light, Ovo Labs hopes it will become standard practice in IVF.
It will also need money.
To that end, Ovo Labs today announced it has secured4.6mn, its first batch of external funding.
Their work shed light on why egg quality declines with age and the potential therapies.
By reducing genetic errors, Ovo Labs hopes to improve the chances of successful pregnancies.
Story bySion Geschwindt
Sion is a freelance science and technology reporter, specialising in climate and energy.
